JH
Jonathan Haber

Distinguish safe sensations from genuinely dangerous signals

Learn to tell "the brain alarming" apart from "the body warning" so you can track safely.

Key takeaways

  • What it is: Learn to tell "the brain alarming" apart from "the body warning" so you can track safely.
  • Why it works: Not every sensation calls for observation — some are tissue-damage signals that require medical response. The ability to distinguish ordinary (if alarming) neuroplastic sensation from signals of acute structural damage is what makes somatic tracking safe practice rather than reckless. The brain’s alarm volume is a notoriously unreliable indicator of tissue danger in neuroplastic pain — high alarm does not equal high danger, but zero alarm does not equal safe to ignore either.
  • Evidence: Established clinical or therapeutic practice.
  • Avoid: Practicing somatic tracking on sensations that warrant medical evaluation because "I know my pain is all in my head." Neuroplastic pain is real brain activity — but new, worsening, or flagged pain requires clinical assessment first.

Why it works

Not every sensation calls for observation — some are tissue-damage signals that require medical response. The ability to distinguish ordinary (if alarming) neuroplastic sensation from signals of acute structural damage is what makes somatic tracking safe practice rather than reckless. The brain’s alarm volume is a notoriously unreliable indicator of tissue danger in neuroplastic pain — high alarm does not equal high danger, but zero alarm does not equal safe to ignore either.

How to do it

  1. 1Know your "red flag" symptoms that require immediate medical attention: sudden severe change, loss of bladder/bowel control, pain after new injury, fever with pain.
  2. 2In the absence of red flags, a familiar chronic pain pattern is a reasonable candidate for somatic tracking.
  3. 3If a sensation is new or qualitatively different from the chronic pattern, pause and evaluate before tracking.
  4. 4When in doubt, track with a clinician present rather than alone.

What the evidence says

Clinical practice

The distinction between neuroplastic and nociceptive pain signals is a well-established clinical framework in pain neuroscience; teaching patients to recognize the difference is a component of pain neuroscience education (PNE), which has its own evidence base.

Honest caveat: The ability to self-distinguish neuroplastic from structural signals is imperfect; this practice reduces risk but does not replace medical assessment for new or changing pain.

References
  • — Louw et al. (2011), pain neuroscience education meta-analysis, Journal of Manual and Manipulative Therapy

Common mistake

Practicing somatic tracking on sensations that warrant medical evaluation because "I know my pain is all in my head." Neuroplastic pain is real brain activity — but new, worsening, or flagged pain requires clinical assessment first.

IX Coach displays a brief red-flag checklist before any somatic tracking session and does not continue if you endorse any flags — deferring to medical guidance rather than treating everything as safe to track.

Practice this with IX Coach →

Related practices